HALO — Halozyme Therapeutics, Inc. stock price, charts and financials

QT63Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
83.23
+0.96+1.17%
OverviewShort InterestFilings
HALOQT63Halozyme Therapeutics, Inc.·NASDAQ
83.23+1.17%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 09, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 09, 20263Initial statement of beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 11, 202610-QQuarterly report
May 11, 20268-KCurrent report
May 07, 20268-KCurrent report
May 07, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
May 05, 20264Statement of changes in beneficial ownership
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 30, 20268-KCurrent report
Apr 24, 20268-KCurrent report
Apr 07, 20264Statement of changes in beneficial ownership
#1 / 25 of 340
Page
▼
/ 14